Valeria Herdea | Medicine and Health Sciences | Cross-disciplinary Excellence Award

Published on by Research Hypothesis

Dr. Valeria Herdea | Medicine and Health Sciences | Cross-disciplinary Excellence Award

Dr. Valeria Herdea | Medicine and Health Sciences | Senior Consultant Family Medicine at George Emil Palade University of Medicine | Romania

Dr. Valeria Herdea is a dedicated medical academic and researcher specializing in pediatrics, with a strong focus on advancing child health through evidence-based research and responsible medical communication. She is affiliated with the George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Târgu Mureș, where her education and advanced academic training have provided a solid foundation in clinical pediatrics, public health, and research methodology. Her professional experience includes active involvement in academic research, scholarly writing, and collaborative projects that address critical issues in pediatric care, particularly the influence of medical information on parental decision-making and child health outcomes. Dr. Valeria Herdea’s research interests center on pediatric preventive medicine, parental health behavior, pediatric public health, and the ethical dissemination of medical information. Dr. Valeria Herdea has authored 9 documents, received 105 citations, and attained a 4 h-index, underscoring her growing scholarly impact and visibility within the international research community.

Citation Metrics (Scopus)

150

120

90

60

30

0

Citations
105

Documents
9

h-index
4

🟦 Citations         🟥 Documents      🟩 h-index

View Scopus Profile

Featured Publications

Assessing the Effects of Medical Information on Parental Self-Medication Behaviors for Children’s Health: A Comparative Analysis
– Medicina (Lithuania), Open Access
Citations: 1

Natalya Semenova | Medicine and Health Sciences | Women Researcher Award

Published on by Research Hypothesis

Dr. Natalya Semenova | Medicine and Health Sciences | Women Researcher Award

Dr. Natalya Semenova | Medicine and Health Sciences | Chief Researcher at Scientific Сentre for Family Health and Human Reproduction Problem | Russia 

Dr. Natalya Semenova is a highly accomplished female biomedical scientist and chief researcher recognized for her significant contributions to pathological physiology, reproductive health, and aging research. She holds a Ph.D. in Biological Sciences and has developed a strong academic foundation through advanced training in experimental biology, human reproduction, and translational medical science at leading scientific institutions. Dr. Natalya Semenova has built an extensive professional career at a federal-level public scientific research center, where she has led and contributed to numerous multidisciplinary research initiatives focused on women’s health, endocrine disorders, microbiome regulation, oxidative stress, and age-related diseases. Her professional experience reflects deep expertise in designing experimental studies, clinical-biological data interpretation, biomarker analysis, and the development of pathogenetically grounded therapeutic and preventive strategies. In the middle of her academic career profile, Dr. Natalya Semenova has authored 156 documents, received 685 citations, and achieved a 12 h-index, demonstrating consistent research productivity and measurable scholarly impact within the international scientific community.

Citation Metrics (Scopus)

1000

800

600

400

200

0

Citations
685

Documents
156

h-index
12

🟦 Citations     🟥 Documents    🟩 h-index

View Scopus Profile

Featured Publications

Optimal Algorithm for Gut Microbiota Differentiation: A Pilot Study of Adolescents with Different Body Weights
– Frontiers in Bioscience (Scholar Edition)
Phosphatidylethanol 16:0/18:1PEth as a Biomarker of Alcohol Consumption during Pregnancy
– Bulletin of Experimental Biology and Medicine
Histostructure of the Hippocampus in Male and Female Wistar Rats with Diet-Induced Visceral Obesity and after Diet Correction
– Bulletin of Experimental Biology and Medicine
Pregnancy and Alcohol: Parameters of Endogenous Intoxication Depending on Blood Phosphatidylethanol Levels
– Human Ecology
Comparative Assessment of the Gut Microbiome by Microbiological and Molecular-Genetic Methods in Sleep Disorders
– Clinical Laboratory Diagnostics

Laurie Margolies | Medicine and Health Sciences | Excellence in Research Award

Published on by Research Hypothesis

Dr. Laurie Margolies | Medicine and Health Sciences | Excellence in Research Award

Dr. Laurie Margolies | Medicine and Health Sciences | MD at Icahn School of Medicine at Mount Sinai | United States

Dr. Laurie Margolies is a distinguished academic physician and internationally recognized expert in breast imaging and diagnostic radiology, known for her leadership in integrating advanced imaging technologies and artificial intelligence into clinical cancer care. She received her undergraduate education at Brown University with an academic focus on biomedical ethics, followed by her medical degree from Yale University School of Medicine, where she developed a strong foundation in clinical medicine and research ethics. Dr. Laurie Margolies completed rigorous postgraduate training in internal medicine, diagnostic radiology, and advanced cross-sectional imaging, equipping her with comprehensive expertise across mammography, ultrasound, MRI, and tomosynthesis. Professionally, Dr. Laurie Margolies has held progressive academic appointments culminating in a full professorship in diagnostic, molecular, and interventional radiology at a leading academic medical center, while simultaneously serving in senior health-system leadership roles including Vice Chair and System Chief for Breast Imaging.

Citation Metrics (Scopus)

2500

2000

1500

1000

500

0

Citations2177

i10index92

h-index19

🟦 Citations    🟥 Documents    🟩 h-index


View Scopus Profile

Featured Publications

Performance of an Artificial Intelligence Support System on Screening Mammography Cases Proceeding to Stereotactic Biopsy
– Cancers (Open Access)
The Tyrer-Cuzick Risk Model: Is It Effective for All Races?
– Clinical Imaging
Patient Perception of Artificial Intelligence in Breast Imaging: A Pilot Survey Study
– Clinical Imaging
Suspicion for Sarcoma: Clinical Presentation, Multi-Modality Imaging Evaluation, and Ultrasound Artificial Intelligence-Based Decision Support
– Cancers (Open Access)
Breast Lymphoma: Imaging Features, Clinical Presentation, and Ultrasound Artificial Intelligence Decision Support
– Clinical Imaging
Artificial Intelligence for Assessment of Digital Mammography Positioning Reveals Persistent Challenges
– Journal of Breast Imaging
Breast Arterial Calcifications on Mammography: A Review of the Literature
– Review Article
Identifying Frequently Endorsed Benefits and Barriers to Breast Cancer Screening for African-Born Women in the NYC Metropolitan Area: A Pilot Study
– Journal of Racial and Ethnic Health Disparities
Low-Dose Chest CT: Participating in the Rise of Breast Density Awareness
– Journal of Women’s Health

Peng-Sheng Zheng | Medicine and Health Sciences | Research Excellence Award

Published on by Research Hypothesis

Prof. Peng-Sheng Zheng | Medicine and Health Sciences | Research Excellence Award

Prof. Peng-Sheng Zheng | Medicine and Health Sciences | Professor at Xi’an Jiaotong University | China

Prof. Peng-Sheng Zheng is a distinguished Professor at Xi’an Jiaotong University and an internationally recognized physician-scientist whose career seamlessly integrates advanced medical training, translational research excellence, and global academic leadership. Prof. Peng-Sheng Zheng earned dual M.D./Ph.D. degrees from Bethune Medical University in China and Saga Medical University in Japan, establishing a strong interdisciplinary foundation in clinical medicine and biomedical research. Following doctoral training, Prof. Peng-Sheng Zheng completed prestigious postdoctoral fellowships at Memorial University of Newfoundland in Canada, the U.S. National Institutes of Health (NIH), and the University of Toronto, where he refined expertise in molecular pathology, reproductive immunology, and cancer biology. Prof. Peng-Sheng Zheng has since built an influential academic career marked by sustained research productivity, mentoring, and international collaboration.

Citation Metrics (Scopus)

4000

3000

2000

1000

500

0

Citations2773

i10index85

h-index 31

🟦 Citations        🟥 Documents         🟩 h-index

View Scopus Profile

Featured Publications

GDF15 deficiency hinders human trophoblast invasion to mediate pregnancy loss through downregulating Smad1/5 phosphorylation
– iScience, 2023 
Reproductive effect by rheumatoid arthritis and related autoantibodies
– Review Article 
Mechanism of chromosomal mosaicism in preimplantation embryos and its effect on embryo development
– Review Article 
Strategies and challenges of mesenchymal stem cells-derived extracellular vesicles in infertility
– Review Article 
Exploring the impact of estrogenic endocrine disruptors on cervical cancer progression: A transcriptome analysis and prognostic model development
– Ecotoxicology and Environmental Safety, 2024
ZNF281 facilitates the invasion of cervical cancer cells both in vivo and in vitro
– Cancers, 2024 
Correction to: Absence of EpCAM in cervical cancer cells is involved in slug-induced epithelial–mesenchymal transition
– Cancer Cell International, 2021 

Ping Yuan | Medicine and Health Sciences | Research Excellence Award

Published on by Research Hypothesis

Prof Ping Yuan | Medicine and Health Sciences | Research Excellence Award

Prof Ping Yuan | Medicine and Health Sciences | Research Excellence Award | Principle Investigator | The Sixth Affiliated Hospital, Sun Yat-sen University | China 

Prof. Ping Yuan is a distinguished researcher and professor currently serving as Principal Investigator at the Guangdong Institute of Gastroenterology, The Sixth Affiliated Hospital, Sun Yat-sen University (since January 2017), with prior appointments including Assistant Professor at the Li Ka Shing Institute of Health Sciences, Chinese University of Hong Kong (2010–2016); Postdoctoral Fellow (Stem Cell) at the Genome Institute of Singapore (2006–2010); Research Associate in Molecular Biology at Princeton University (2004–2006); and Visiting Research Fellow in Pathology at Brigham and Women’s Hospital, Boston (2001). He earned his Ph.D. from the Institute of Molecular and Cell Biology, National University of Singapore (completed 2004), after completing an M.S. in Microbiology at the Wuhan Institute of Virology, Chinese Academy of Sciences, and a B.S. from the School of Biological Sciences, Central China Normal University. Over his career, Prof. Ping Yuan has secured multiple competitive research grants — including support from the National Natural Science Foundation of China for work on YAP-associated super-enhancers in stem cells (Grant 31970674, 2020–2023), inhibition of glioblastoma stem cell proliferation (Grant 8177110391, 2018–2021), and the role of DNA repair factor Rif1 in teratocarcinoma formation (Grant 81372162, 2014–2017), as well as funding from the Research Grants Council of Hong Kong for building an in-vitro system to reconstitute female germ-lineage cells (Grant 479512, 2013–2016). His research interests center on cancer stem cells, pluripotent stem cells, epigenetic modification, and single-cell RNA sequencing (scRNA-seq), with research skills spanning molecular biology, stem cell biology, epigenetics, in vitro and in vivo functional assays, bioinformatics and genomics. Prof. Ping Yuan has contributed significantly to our understanding of how pathways such as Hippo-YAP regulate stem cell differentiation and how dysregulation may underlie cancer, particularly colorectal and other cancers. His recent work includes demonstration that interference with CAPG induces apoptosis and ferroptosis via the p53 pathway in colorectal cancer cells, and that UCKL1 plays a non-canonical role in ferroptosis defense in colorectal cancer, highlighting potential therapeutic targets. Through his sustained funding, leadership roles, and prolific output, Prof. Ping Yuan has established himself as a leading figure in the intersection of stem cell biology, epigenetics, and cancer research, influencing both basic stem cell science and translational oncology.

Profile:  scopus | ORCID 

Featured Publications

  1. CAPG interference induces apoptosis and ferroptosis in colorectal cancer cells through the P53 pathway. (2023). Molecular and Cellular Probes.

  2. Non-canonical role of UCKL1 on ferroptosis defence in colorectal cancer. (2023). EBioMedicine.

  3. Silence of a dependence receptor CSF1R in colorectal cancer cells activates tumor-associated macrophages. (2022). Journal for Immunotherapy of Cancer.

  4. Lin28 inhibits the differentiation from mouse embryonic stem cells to glial lineage cells through upregulation of Yap1. (2021). Stem Cells International.

  5. Hippo-YAP signaling controls lineage differentiation of mouse embryonic stem cells through modulating the formation of super-enhancers. (2020). Nucleic Acids Research, 48(13), 7182–7196.

  6. CFTR constrains the differentiation from mouse embryonic stem cells to intestine lineage cells. (2019). Biochemical and Biophysical Research Communications.

  7. Differentiation of female Oct4-GFP embryonic stem cells into germ lineage cells. (2018). Cell Biology International

Mingyao Liu | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Prof. Mingyao Liu | Medicine and Health Sciences | Best Researcher Award

Prof. Mingyao Liu | Medicine and Health Sciences | Best Researcher Award | Professor | University of Toronto | Canada

Prof. Mingyao Liu, MD, MSc, is an internationally recognized biomedical scientist and academic leader renowned for his pioneering contributions to lung injury, transplantation immunology, and regenerative medicine. He currently serves as the James & Mary Davie Chair in Lung Injury, Repair and Regeneration at the University Health Network and as Director of the Institute of Medical Science at the University of Toronto, where he leads multidisciplinary teams advancing translational research in organ preservation and immunomodulation. Prof. Mingyao Liu obtained his M.D. and M.Sc. in Pathophysiology from the Second Military Medical University in Shanghai, China, followed by an intensive postdoctoral fellowship at the SickKids Research Institute in Toronto, Canada, where he began his journey into molecular mechanisms of lung disease and transplant biology. His professional experience spans decades of leadership roles, including Senior Scientist at the Toronto General Hospital Research Institute and Full Professor in the Department of Surgery at the University of Toronto, with cross-appointments in Medicine and Physiology. Prof. Mingyao Liu’s research interests focus on understanding ischemia-reperfusion injury, immune tolerance in organ transplantation, and cellular mechanisms driving lung regeneration. His laboratory employs advanced molecular biology, gene editing, single-cell transcriptomics, and ex vivo organ perfusion systems to identify therapeutic targets that improve graft survival and repair outcomes. His scientific expertise is further reflected through numerous publications in high-impact journals such as Transplantation, Scientific Reports, NPJ Digital Medicine, and The American Journal of Transplantation. Prof. Mingyao Liu has received multiple prestigious awards, including the Queen Elizabeth II Diamond Jubilee Medal, the Premier’s Research Excellence Award, and the Mel Silverman Mentorship Award, highlighting both his research excellence and commitment to nurturing the next generation of scientists. As a dedicated member of numerous professional societies such as the American Thoracic Society, The Transplantation Society, and the International Society of Heart and Lung Transplantation, he plays a significant role in shaping global biomedical research discourse. Prof. Mingyao Liu’s career reflects a rare combination of innovative science, effective leadership, and lifelong mentorship, making him one of the foremost authorities in lung transplant biology. His continued contributions are shaping the future of regenerative medicine through translational discoveries that bridge laboratory innovation with clinical excellence, reinforcing his position as a global leader dedicated to improving outcomes for patients with severe pulmonary diseases.

Profile: Scopus | ORCID | Google Scholar

Featured Publications

  1. Liu, M. (2025). Permissive immunosuppression facilitates the expansion of ex vivo administered regulatory T cells in the lung allograft. Scientific Reports. 1 citation.

  2. Liu, M. (2025). Ischemia/Reperfusion upregulates genes related to PANoptosis in human lung transplants. Transplantation. 3 citations.

  3. Liu, M. (2025). L-Alanyl-L-Glutamine alleviated ischemia-reperfusion injury and primary graft dysfunction in rat lung transplants. Transplantation. 2 citations.

  4. Liu, M. (2025). Ex vivo delivery of recombinant IL-10 to human donor lungs. JHLT Open. 0 citations.

  5. Liu, M. (2025). Protective effects of 10 °C preservation on donor lungs with lipopolysaccharide-induced acute lung injury. Conference Proceedings. 1 citation.

  6. Liu, M. (2024). Improving prognostic accuracy in lung transplantation using unique features of isolated human lung radiographs. NPJ Digital Medicine. 3 citations.

  7. Liu, M. (2024). Ischemia-reperfusion responses in human lung transplants at the single-cell resolution. American Journal of Transplantation. 5 citations.

 

Gabriela Gurau | Medicine and Health Sciences | Excellence in Research Award

Published on by Research Hypothesis

Prof. Dr. Gabriela Gurau | Medicine and Health Sciences | Excellence in Research Award 

Prof. Dr. Gabriela Gurau | Medicine and Health Sciences | Excellence in Research Award | Physician | The Lower Danube University | Romania

Prof. Dr. Gabriela Gurău is an accomplished Romanian medical researcher, clinician, and academic leader with extensive contributions to the fields of clinical laboratory medicine, infectious diseases, and metabolic disorders. She holds a Ph.D. in Medical Sciences from the University of Medicine and Pharmacy “Carol Davila,” Bucharest, complemented by advanced certifications in diabetes, nutrition, metabolic diseases, and laboratory medicine from the Ministry of Health and the Training Center for Doctors and Pharmacists. Currently serving as Professor Habil. at the Faculty of Medicine and Pharmacy, University “Dunarea de Jos” of Galați, she also fulfills the role of Head of the Clinical Laboratory at the Clinical Emergency Hospital for Children “Sfântul Ioan.” Throughout her professional journey, Prof. Dr. Gabriela Gurău has demonstrated exceptional skill in integrating clinical diagnostics with translational research, focusing on pediatric infections, antibiotic resistance, microbiological profiling, and metabolic disorders. Her research interests include pathogen surveillance, microbial resistance mechanisms, pediatric metabolic health, and the interplay between microbiota and systemic diseases. With an active research portfolio, she has participated in numerous national and international projects, including innovative studies funded by PN II, AUF, and institutional grants, contributing significantly to Romania’s biomedical research landscape. She is the author and co-author of impactful peer-reviewed articles published in leading scientific journals indexed in Scopus and Web of Science, such as Life, Viruses, International Journal of Molecular Sciences, Applied Sciences, and Infection and Drug Resistance, reflecting her commitment to scientific excellence and knowledge dissemination. Her strong research skills span molecular diagnostics, laboratory analytics, data interpretation, and interdisciplinary collaboration, all of which reinforce her as a versatile scientist bridging clinical medicine and public health research. Recognized for her scholarly achievements and leadership, Prof. Dr. Gabriela Gurău has been a key figure in organizing medical conferences like MedFarmLab, served as Head of the Department of Morphological and Functional Sciences, and contributed actively to professional societies and research committees. Her dedication has earned her respect as a mentor, educator, and innovator in Romanian academia. Prof. Dr. Gabriela Gurău’s career exemplifies a synthesis of scientific rigor, community service, and academic distinction, underpinned by her mission to improve pediatric healthcare outcomes through evidence-based research. With her established reputation, international collaborations, and evolving leadership roles, Prof. Dr. Gabriela Gurău continues to advance the frontiers of laboratory medicine and inspire emerging generations of biomedical scientists worldwide.

Profile: Scopus | ORCID | Google Scholar

Featured Publications 

  1. Matache, E. R., Gurău, G., Stoian, V. I., Zaharia, A. E., Ciocoiu, M., Maftei, N. M., & Tutunaru, D. (2025). Bordetella pertussis in children: A retrospective analysis of the clinical impact and the role of vaccination. Life, 15(10), 1514.

  2. Matache, E. R., Gurău, G., Raileanu, C. R., Zaharescu, A., Popa, G. V., Maftei, N. M., & Tutunaru, D. (2025). Pathogen profile of children hospitalised with viral respiratory infections in Galati County, Romania. Viruses, 17(4), 586.

  3. Ursu, M., Cretu-Stuparu, M., Gurău, G., Nitoi, L. C., Nechita, A., & Arbune, M. (2024). An epidemiological perspective on new pediatric cases of type 1 diabetes and vitamin D deficiency in South-East Romania: A retrospective study. Children, 11(10), 1162.

  4. Radaschin, D. S., Iancu, A. V., Ionescu, A. M., Gurău, G., Niculet, E., Bujoreanu, F. C., & Tatu, A. L. (2024). An eastern county from a European eastern country—The characteristics of cutaneous microbiome in psoriasis patients—Preliminary results. Life, 14(6), 678.

  5. Radaschin, D. S., Iancu, A. V., Ionescu, A. M., Gurău, G., Niculet, E., Bujoreanu, F. C., & Popa, L. G. (2024). Comparative analysis of the cutaneous microbiome in psoriasis patients and healthy individuals—Insights into microbial dysbiosis: Final results. International Journal of Molecular Sciences, 25(19), 10583.

  6. Iancu, A. V., Arbune, M., Zaharia, E. A., Tutunaru, D., Maftei, N. M., Peptine, L. D., Tocu, G., & Gurău, G. (2023). Prevalence and antibiotic resistance of Enterococcus spp.: A retrospective study in hospitals of Southeast Romania. Applied Sciences, 13(6), 3866.

  7. Arbune, M., Gurău, G., Niculet, E., Iancu, A. V., Lupasteanu, G., Fotea, S., Vasile, M. C., & Tatu, A. L. (2021). Prevalence of antibiotic resistance of ESKAPE pathogens over five years in an infectious diseases hospital from South-East Romania. Infection and Drug Resistance, 14, 2369–2378.

 

Mengting Zhang | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Ms. Mengting Zhang | Medicine and Health Sciences | Best Researcher Award

Miss | Guangdong Medical University | Hong Kong

Ms. Mengting Zhang is a highly motivated and emerging scholar in the field of Medicine and Health Sciences, currently affiliated with Guangdong Medical University, Hong Kong, where she has established herself as a promising researcher contributing significantly to global advancements in medical and clinical research. With a strong academic foundation supported by a Doctoral degree in Medicine, Ms. Zhang has cultivated a comprehensive understanding of medical sciences, pharmacology, and translational research methodologies. Her educational journey reflects a deep commitment to precision, innovation, and interdisciplinary collaboration, equipping her with the skills to integrate clinical data, biomedical insights, and analytical modeling for impactful healthcare outcomes. Throughout her professional career, Ms. Zhang has demonstrated excellence in multiple research domains, including pharmacovigilance, clinical pharmacology, oral oncology, and biomedical informatics. She has been extensively involved in projects focusing on adverse drug event detection, molecular disease pathways, and bioinformatics-based health analysis, which are central to improving patient safety and therapeutic efficacy. Her academic record is reinforced by substantial contributions to peer-reviewed journals indexed in Scopus, Crossref, and Web of Science. Ms. Zhang has authored 11 documents, received 33 citations, and holds an h-index of 4, underscoring her consistent academic influence and growing recognition in the research community. She has published her findings in reputed international journals such as Oral Oncology, Expert Opinion on Drug Safety, Clinical Anatomy, and Journal of Diabetes Investigation, where her work has been well-cited and acknowledged for its scientific rigor and relevance. Her research explores complex relationships between genetics, drug response, and oral health conditions, with a focus on integrating real-world pharmacovigilance data and molecular evidence to enhance the accuracy of clinical outcomes. Ms. Zhang’s research skills encompass advanced data analysis, systematic review techniques, visual scientometrics using CiteSpace and VOSviewer, clinical trial evaluation, and statistical modeling. Professionally, she has collaborated with national and international researchers, contributing to studies utilizing FDA adverse event reporting systems and developing visual bibliometric maps that identify emerging medical trends. Her dedication to accuracy, methodological clarity, and ethical research practices has earned her recognition as a dependable contributor to academic development. Beyond research, Ms. Zhang is engaged in mentoring, peer-reviewing, and participating in collaborative scientific platforms that promote interdisciplinary learning and global knowledge sharing. Her commitment to innovation and collaboration highlights her as a future leader in the scientific community, capable of influencing both clinical and policy-level improvements in healthcare. Ms. Zhang’s achievements have positioned her as a potential candidate for several international honors and awards in biomedical sciences, including recognitions for research excellence and contribution to pharmacological safety evaluation. In conclusion, Ms. Mengting Zhang embodies academic integrity, scientific precision, and a vision for global medical progress.

Profile:  ORCID | Scopus

Featured Publications

  1. Zhang, M. (2025). Comment on “Uncovering chromatin factor landscapes in head and neck squamous cell carcinoma.” Oral Oncology. Citations: 7.

  2. Zhang, M. (2025). Comment on “Tooth Anomalies in Patients With Nonsyndromic Orofacial Cleft: A Systematic Review and Meta‐Analysis.” Oral Diseases. Citations: 5.

  3. Zhang, M. (2025). A real-world disproportionality analysis of the FDA adverse event reporting system events for ibuprofen. Expert Opinion on Drug Safety. Citations: 8.

  4. Zhang, M. (2024). A real‐world disproportionality analysis of semaglutide: Post‐marketing pharmacovigilance data. Journal of Diabetes Investigation. Citations: 6.

  5. Zhang, M. (2024). Research advances and trends in anatomy from 2013 to 2023: A visual analysis based on CiteSpace and VOSviewer. Clinical Anatomy. Citations: 7.

 

Qianheng Jin | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Dr. Qianheng Jin | Medicine and Health Sciences | Best Researcher Award

Dr. Qianheng Jin | Medicine and Health Sciences | Attending physician | Suzhou Ruihua Orthopedic Hospital | China

Dr. Qianheng Jin is a highly accomplished physician and researcher whose work bridges clinical orthopedics and regenerative medicine. With a career rooted in advancing patient care, he has combined surgical expertise with pioneering biomedical research, focusing on innovative approaches in tissue engineering, wound healing, and bioprinting. His professional journey highlights a consistent commitment to improving treatment outcomes, particularly in complex reconstructive procedures and vascularized tissue regeneration. Dr. Qianheng Jin is recognized for integrating advanced research into clinical practice, making significant contributions to both academic science and applied medical solutions that directly benefit patients.

Professional Profile 

Education

Dr. Qianheng Jin pursued his advanced medical and doctoral studies at Soochow University, where he specialized in the fields of orthopedic surgery, regenerative medicine, and biomedical engineering. His academic training emphasized translational research, with a focus on developing engineered tissues and vascularized constructs capable of improving clinical outcomes in reconstructive surgery. Through rigorous education and extensive research engagement, Dr. Qianheng Jin has cultivated deep expertise in surgical techniques, tissue biology, and biomaterial applications, which now form the foundation of his academic and clinical contributions.

Experience

Dr. Qianheng Jin serves as a physician at Suzhou Ruihua Orthopedic Hospital, where he applies his knowledge in treating complex injuries and performing advanced replantation surgeries. His professional experience is characterized by a balance between hands-on surgical practice and groundbreaking laboratory-based innovations. In his role, he has contributed to the establishment of emergency protocols for major limb replantation, leading to significant improvements in patient outcomes. Beyond clinical service, he has actively participated in collaborative research projects that link medical institutions and international academic communities. This blend of professional experience underscores his ability to merge theory and practice while fostering a collaborative research culture.

Research Interest

The research interests of Dr. Qianheng Jin lie in the intersection of regenerative medicine, bioprinting technologies, and clinical orthopedics. His work particularly focuses on the development of engineered dermal tissues, small-diameter vascular grafts, and advanced wound healing strategies. He has contributed to the exploration of bioprinted vascularized constructs that mimic natural tissue structures and improve graft survival. Additionally, his studies extend to investigating molecular mechanisms that influence tissue repair and regeneration, offering valuable insights into translational applications. Dr. Qianheng Jin work demonstrates his dedication to advancing clinical solutions through innovative biomedical technologies that address unmet challenges in reconstructive medicine.

Award

Dr. Qianheng Jin has been recognized for his contributions through academic excellence, impactful research, and clinical innovation. His published works in highly respected journals highlight his role as a thought leader in regenerative medicine and bioprinting. These achievements underscore his eligibility for awards that honor research excellence, clinical impact, and international collaboration. His record reflects not only scholarly productivity but also the translation of research into practical applications, affirming his status as a deserving candidate for this nomination.

Selected Publication

  • A multidisciplinary emergency protocol reduces revascularization time in major upper and lower limb replantations (2025) – 18 Citations

  • Bioprinted dermis with human adipose tissue‐derived microvascular fragments promotes wound healing (2024) – 32 Citations

  • Engineered dermis loaded with confining forces promotes full-thickness wound healing by enhancing vascularisation and epithelialisation (2023) – 27 Citations

  • Bioprinting small diameter blood vessel constructs with an endothelial and smooth muscle cell bilayer in a single step (2020) – 41 Citations

Conclusion

Dr. Qianheng Jin exemplifies the qualities of an outstanding clinician-researcher whose dedication to advancing science and medicine has resulted in significant contributions to orthopedic surgery, regenerative medicine, and biomedical engineering. His career reflects a rare balance between direct patient care and innovative research, producing outcomes that resonate within both clinical practice and global academic discourse. With a growing body of high-impact publications, international collaborations, and leadership in clinical innovation, Dr. Qianheng Jin continues to pave the way for advancements in reconstructive medicine. His achievements, professional dedication, and potential for future breakthroughs make him an exceptional candidate for this award nomination, representing both scientific excellence and meaningful societal contribution.

 

Louisa Mokoena | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Dr. Louisa Mokoena | Medicine and Health Sciences | Best Researcher Award

Dr. Louisa Mokoena | Medicine and Health Sciences | Lecturer | University Of Johannesburg | South Africa

Dr. Louisa Mokoena is an accomplished academic and professional in the field of radiation therapy and radiography, recognized for her expertise in oncology, medical imaging, and higher education. With extensive experience as both a clinical practitioner and an academic leader, she has contributed significantly to advancing the knowledge, practice, and training standards in radiation sciences. Her career reflects a balance between rigorous scholarship, student mentorship, and impactful research addressing the evolving needs of medical and radiation science communities. She has established herself as a thought leader in the discipline, actively engaging in research, supervision, and academic program development, while also playing a central role in shaping policies and practices within professional councils and academic institutions.

Professional Profile 

Education

Dr. Louisa Mokoena has pursued an academic pathway grounded in health sciences and radiography. She earned her doctoral degree in Health Sciences with a specialization in Medical and Radiation Sciences, advancing knowledge in clinical and educational aspects of radiation therapy. Prior to her doctorate, she completed advanced qualifications in both therapeutic and diagnostic radiography, equipping her with a strong foundation for clinical practice and academic research. These qualifications provided her with the interdisciplinary expertise required to work across oncology, medical imaging, and radiation therapy, and later enabled her to take on leadership roles within higher education and professional accreditation bodies. Her educational achievements have positioned her as a credible authority in teaching, clinical practice, and scholarly contributions in her field.

Experience

Throughout her career, Dr. Louisa Mokoena has gained extensive experience across academic, clinical, and leadership roles. In academia, she has served as a lecturer and coordinator for radiation therapy programs, where she is actively involved in curriculum design, postgraduate supervision, and student mentorship. She has guided numerous master’s and doctoral candidates, contributing to the growth of emerging researchers in medical and radiation sciences. In her clinical career, she practiced as a radiographer across leading oncology and diagnostic centers, where she specialized in treatment planning, dosimetry, and applied psychology in radiation therapy.

Research Interest

Dr. Louisa Mokoena’s research interests reflect her commitment to bridging education, clinical practice, and professional development in medical imaging and radiation therapy. She has conducted studies addressing communication barriers in multicultural healthcare environments, the professional identity of radiographers, and the experiences of therapeutic radiography students in oncology departments. Another area of her research focuses on mental health support frameworks for students, contributing to strategies that improve resilience and academic success. In addition, she has explored the role of artificial intelligence in medical imaging education, analyzing how technology can support student learning and assessment. Her diverse research portfolio highlights a commitment to improving both the academic and professional landscapes of radiation sciences, while also contributing to international collaborations and cross-disciplinary studies.

Award

Dr. Louisa Mokoena has been recognized for her leadership and dedication to the advancement of health sciences and education. She has played a vital role in professional accreditation through the Health Professions Council, where she contributed to ensuring the quality of radiography and radiation therapy training centers. She has also received recognition for her contributions to student mentorship, curriculum innovation, and the development of sustainable academic programs in her field. Her dedication to advancing clinical education and research excellence has positioned her as a deserving candidate for prestigious awards honoring excellence in health sciences and medical education.

Selected Publication

  • Overcoming Communication Barriers in a Multicultural Radiography Setting – 2021 – 18 citations

  • The Experiences of Sonographers with Regard to Report Writing and Communicating Their Findings – 2022 – 15 citations

  • Diagnostic Radiographers’ Perceptions of Professional Identity in Johannesburg, Gauteng, South Africa – 2024 – 12 citations

  • Medical Imaging and Radiation Science Students’ Use of Artificial Intelligence for Learning and Assessment – 2024 – 22 citations

  • Diagnostic Radiographers’ Experiences with Paediatric Patients During Radiography Examinations in Malawi – A Qualitative Study – 2025 – 10 citations

Conclusion

Dr. Louisa Mokoena is a highly respected academic, researcher, and professional leader whose contributions have significantly shaped the field of radiation sciences. Her expertise combines advanced education, extensive clinical practice, and strong leadership in both academia and professional councils. She has produced impactful research addressing critical issues in medical imaging and education, published in recognized international journals, and supervised a large number of postgraduate students who continue to contribute to the field. Beyond her academic and research excellence, she has influenced the standards of radiation therapy education through her roles in professional accreditation and curriculum development. Dr. Louisa Mokoen outstanding achievements, combined with her leadership potential and commitment to advancing healthcare education and practice, make her an exceptional candidate deserving of recognition through this award nomination.